![](/img/cover-not-exists.png)
Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study
Mago, Rajnish, Forero, Giovanna, Greenberg, William M., Gommoll, Carl, Chen, ChangzhengVolume:
33
Language:
english
Journal:
Clinical Drug Investigation
DOI:
10.1007/s40261-013-0126-5
Date:
October, 2013
File:
PDF, 288 KB
english, 2013